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1. Introduction 
In the past 20 years, mesoporous materials have been attracted great attention due to their 
significant feature of large surface area, ordered mesoporous structure, tunable pore size 
and volume, and well-defined surface property. They have many potential applications, 
such as catalysis, adsorption/separation, biomedicine, etc. [1]. Recently, the studies of the 
applications of mesoporous materials have been expanded into the field of biomaterials 
science. A new class of bioactive glass, referred to as mesoporous bioactive glass (MBG), 
was first developed in 2004. This material has a highly ordered mesopore channel structure 
with a pore size ranging from 5–20 nm [1]. Compared to non-mesopore bioactive glass (BG), 
MBG possesses a more optimal surface area, pore volume and improved in vitro apatite 
mineralization in simulated body fluids [1,2]. Vallet-Regí et al. has systematically 
investigated the in vitro apatite formation of different types of mesoporous materials, and 
they demonstrated that an apatite-like layer can be formed on the surfaces of Mobil 
Composition of Matters (MCM)-48, hexagonal mesoporous silica (SBA-15), phosphorous-
doped MCM-41, bioglass-containing MCM-41 and ordered mesoporous MBG, allowing 
their use in biomedical enineering for tissue regeneration [2-4]. Chang et al. has found that 
MBG particles can be used for a bioactive drug-delivery system [5,6]. Our study has shown 
that MBG powders, when incorporated into a poly (lactide-co-glycolide) (PLGA) film, 
significantly enhance the apatite-mineralization ability and cell response of PLGA films. 
compared to BG [7]. These studies suggest that MBG is a very promising bioactive material 
with respect to bone regeneration. It is known that for bone defect repair, tissue engineering 
represents an optional method by creating three-dimensional (3D) porous scaffolds which 
will have more advantages than powders or granules as 3D scaffolds will provide an 
interconnected macroporous network to allow cell migration, nutrient delivery, bone 
ingrowth, and eventually vascularization [8]. For this reason, we try to apply MBG for bone 
tissue engineering by developing MBG scaffolds. However, one of the main disadvantages 
of MBG scaffolds is their low mechanical strength and high brittleness; the other issue is that 
they have very quick degradation, which leads to an unstable surface for bone cell growth 
limiting their applications. 
Silk fibroin, as a new family of native biomaterials, has been widely studied for bone and 
cartilage repair applications in the form of pure silk or its composite scaffolds [9-14]. 
Compared to traditional synthetic polymer materials, such as PLGA and poly(3-
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hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), the chief advantage of silk fibroin is its 
water-soluble nature, which eliminates the need for organic solvents, that tend to be highly 
cytotoxic in the process of scaffold preparation [15]. Other advantages of silk scaffolds are 
their excellent mechanical properties, controllable biodegradability and cytocompatibility 
[15-17]. However, for the purposes of bone tissue engineering, the osteoconductivity of pure 
silk scaffolds is suboptimal. It is expected that combining MBG with silk to produce 
MBG/silk composite scaffolds would greatly improve their physio-chemical and osteogenic 
properties for bone tissue engineering application. Therefore, in this chapter, we will 
introduce the research development of MBG/silk scaffolds for bone tissue engineering. 
2. Preparation, characterization, physio-chemistry and biological property of 
MBG/silk composite scaffolds 
In the section, we will introduce the novel development of MBG/silk composite scaffolds 
prepared by two methods for bone tissue engineering. One is that we will use silk-modified 
MBG scaffolds to enhance mechanical, biological and drug-delivery properties for bone 
regeneration application; the other is to incorporate MBG powders into silk scaffolds to 
improve their physio-chemistry and in vivo osteogenesis. 
2.1 Silk-modified MBG scaffolds 
2.1.1 Composition optimization and characterization of silk-modified MBG scaffolds 
To prepare and optimize MBG scaffolds, a series of MBG scaffolds with varied composition 
(molar composition: 100Si; 90Si-5Ca-5P; 80Si-15Ca-5P and 70Si-25Ca-5P) have been prepared 
by co-template method of P123 (EO20-PO70-EO20) and polyurethane sponges (PUS), in which 
P123, as the template of mesopore formation, creates well-ordered mesoporous channels 
(around 5 nm) and PUS, as the template of large pores, produces hierarchically large pores 
(around 200-400 μm) (Figure 1). Our study has shown that MBG with the composition of 
80Si-15Ca-5P has optimized bioactivity among four scaffolds [18]. Therefore, in this study, 
MBG (80Si-15Ca-5P) was selected for the further study. 
 
 
Fig. 1. SEM (a) and TEM (b) images for the prepared MBG scaffolds. 
(a) (b) 50 nm
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Silk-modified MBG scaffolds were prepared by dip-coating silk fibroin solution (wt. 2.5% 
and 5%) on the surface of scaffold pore walls with the cross linking of ethanol. After 
modification, a smooth silk film had formed on the surface of pore wall (Fig. 2b). Silk-
modified MBG scaffolds showed a more uniform and continuous pore network (Fig. 2b) 
compared to unmodified MBG scaffolds with numerous collapsed and un-continuous 
pore networks due to their brittle nature (Fig. 2c). Silk-modified MBG scaffolds had a 
highly porous structure with the large-pore size of 400μm and maintained high porosity 
(95%). These characteristics indicate that silk-modified MBG scaffolds satisfy the 
requirements of pore structure architecture for cell and blood vessel ingrowth and 
nutrient supply [8]. 
 
 
 
 
 
 
Fig. 2. SEM images for the formed silk layer (see arrow) (a), silk-modified MBG scaffolds (b) 
and un-modified MBG scaffolds (c) [19]. 
2.1.2 Physio-chemistry and biological property of silk-modified MBG scaffolds 
The concentration of silk fibroin plays an important role to influence the compressive 
strength of MBG scaffolds. The compressive strength of pure MBG scaffolds was estimated 
to be 60kPa. Silk modification significantly improved the compressive strength of MBG 
scaffolds, which increases to 120kPa for 2.5%Silk-MBG scaffolds and 250kPa for 5.0%Silk-
MBG scaffolds, a 100 and 300% increase, respectively (Fig. 3). There are two possible 
explanations as to why silk-modification improves the mechanical properties of the MBG 
scaffolds [19]. (1) Silk modification may induce a more uniform and continuous pore 
network within the MBG scaffolds, which, due to their natural brittleness, would otherwise 
have collapsed pore networks and micro-defects (micropores) and which contributes to their 
low mechanical strength; or (2) silk, which has greater mechanical strength than any other 
traditional polymer [15], may form an intertexture within the MBG scaffolds, linking the 
inorganic phase together and, in effect, reinforce the scaffolds [20]. 
By comparison, the compressive strength of hydroxyapatite andβ-Tricalcium phosphate is 
only 30kPa [21] and 50kPa [22], when their porosity is greater than 90%. The compressive 
strength of spongy bone (not the strut) is in the range of 0.2–4 MPa [23]. Therefore, the 
silk-modified MBG scaffolds fall within this range and therefore mimic that of cancellous 
bone. 
(a) (b) (c) 
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Fig. 3. The effect of silk concentration on the mechanical strength of MBG scaffolds [19].  
 
 
 
 
Fig. 4. Drug release from silk-modified and unmodified of MBG scaffolds [19]. 
Drug delivery represents another major challenge for scaffolds applicable for bone tissue 
engineering. In traditional scaffolds it was very difficult to combine the function of drug 
delivery due to the absence of a nano-pore structure. Due to the existence of well-ordered 
mesoporous structure in the MBG scaffolds, they can be used for the drug carrier. 
Dexamethasone can be easily loaded in the matrix of scaffolds by a simple soaking method. 
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The 5.0%Silk-MBG scaffolds had a decreased burst release compared to MBG scaffolds, and 
maintained a sustained release (Fig. 4). The most likely explanation for this is that the 5% silk 
solution forms a relatively dense silk film on the surface of pore walls which slows the drug 
release; however, over time the silk will begin to degrade and its effect on the release kinetics 
will therefore abate. This was evident by the fact that there was no discernible difference of the 
drug-release rate of the 5.0%Silk-MBG scaffold compared to the 2.5%Silk-MBG and the MBG 
scaffolds (Fig. 4). Further study has shown that after the drug release in phosphate buffer 
solution (PBS), a thin Ca-P layer of micro-particles was found to have been deposited on the 
surface of pore walls (Fig. 5). The formed Ca-P layer, one the one hand, will have an inhibitory 
effect on drug release [24]; On the other hand, it is indicated that silk-modified MBG scaffolds 
maintained the bioactivity of the surface chemistry as the Ca-P formation ability was regarded 
as one of important factor for bioceramics according to Kokubo’s view [25]. 
 
 
Fig. 5. SEM images for silk-modified MBG scaffolds after drug release in PBS.  
The biological properties of silk-modified MBG scaffolds were further investigated by 
evaluating the attachment, proliferation, differentiation and bone cell-relative gene (alkaline 
phosphatase activity (ALP) and osteocalcin (OCN)) expression of bone marrow stromal cells 
(BMSC). After 1 day of culture, BMSCs were attached to the surface of the pore walls in all 
three types of scaffolds (Fig. 6). There was no obvious difference in the cell numbers and 
morphology of the attached cells among the scaffold types after one day. After 7 days, 
however, the density of BMSCs on 2.5%Silk-MBG and 5.0Silk-MBG scaffolds was higher 
than that of pure MBG scaffolds, the BMSCs on the 5.0%Silk-MBG scaffolds eventually 
reaching confluence.  High magnification images show that BMSCs on 5.0%Silk-MBG 
scaffolds had a more spread out morphology than those on pure MBG scaffolds and that the 
cells had close contact with the pore walls of 5.0%Silk-MBG scaffolds (Fig. 6).  
Silk modification significantly improved the proliferation and ALP activity of BMSCs on 
MBG scaffolds. At day 1, the number of cells on the silk-modified MBG scaffolds were 
comparable with that of pure MBG scaffolds (Fig. 7a), whereas by day 7, the number of cells 
on the silk-modified MBG scaffolds was significantly higher than that on the pure MBG 
scaffolds (p<0.05). ALP activity was used as an early marker of BMSC differentiation on 
scaffolds. After 7 days of culture, the ALP activity of the cells on all three scaffold types was 
(a) (b) 
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roughly equal (Fig 7b); however, after 14 days the ALP activity of BMSCs in the 5.0%Silk-
MBG scaffolds was greater than that of the other two scaffold types (Fig. 7b). The 
osteoblastic differentiation was further assessed by the mRNA expression of ALP and OCN 
using RT-qPCR method.  There was an upregulation of the osteogenic marker genes of OCN 
and ALP after the modification of MBG scaffolds by silk (Fig. 8). 
 
 
Fig. 6. The morphology of bone marrow stromal cells on the silk-modified and unmodified 
MBG scaffolds after 1 and 7 days of culture [19]. 
From the results above, it is indicated that that silk modification of MBG scaffolds had a 
positive effect on the attachment, proliferation and differentiation of BMSCs [19]. Generally, 
the ionic environment and material surface are two main factors which influence the 
interaction of cells and biomaterials [7,26-29]. In this study, silk modification did not create 
any significant effect on either ionic release or weight loss of MBG scaffolds. It has been 
speculated that the ionic environment and pH value of culture media may not be the most 
important factors affecting the cell response. Therefore, there is a reasonable hypothesis that 
 
www.intechopen.com
 Mesopore Bioglass/Silk Composite Scaffolds for Bone Tissue Engineering 
 
275 
 
 
Fig. 7. The proliferation (a) and ALP activity of bone marrow stromal cells on the silk-
modified and unmodified MBG scaffolds [19]. 
the silk itself may be responsible for enhancing BMSC proliferation and differentiation. It is 
known that, generally, the stable surface of biomaterials enhances cell attachment and 
proliferation, compared to the unstable surface of biomaterials which have a higher rate of 
dissolution [28]. MBG scaffolds have a high rate of degradation leaving their surface 
relatively unstable, and this may affect cell growth. The silk used in this study is the 
relatively stable fibroin, which consists of a β-sheet structure. When applied to the MBG 
scaffolds this silk may provide a relatively stable surface interface to support BMSC 
proliferation and differentiation. It has been reported that silk-functionalized titanium 
surfaces can enhance osteoblast functions [30,31], and also that silk modification of poly 
(D,L-lactic acid) improves ostoblast differentiation [32]. Although the mechanisms 
underlying this stimulatory effect on cell functions remains unclear, the explanation may be 
related to the interaction with specific chemical groups in silk, such as amino acids [15]. 
(a) 
(b
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Fig. 8. The bone-relative gene expression of OCN (a) and ALP (b) of bone marrow stromal 
cells on the silk-modified and unmodified MBG scaffolds [19]. 
2.2 MBG powders-incorporated silk scaffolds 
2.2.1 Preparation, characterization and physio-chmistry of MBG-incorporated silk 
scaffolds 
MBG powders (molar composition: 80Si-15Ca-5P) with a particle size lower than 45μm were 
synthesized by an evaporation-induced self-assembly process according to the publications 
[7]. The obtained MBG powders possess well-ordered mesoporous structure (see Fig. 9a). 
Non-mesoporous bioglass (BG) powders with same composition were synthesized for the 
control materials (Fig. 9b). The surface area and pore volume of MBG are about 400m2/g 
and 0.5cm3/g, respectively, which are obviously higher than those of BG (57 m2/g for 
surface area, 0.09 cm3/g for pore volume). 
Porous MBG/silk scaffolds with 10% MBG (w/w) were fabricated using a freeze-drying 
method. Pure silk and BG/silk scaffolds were prepared by same method for the control 
materials. The silk, MBG/silk and BG/silk scaffolds were highly porous (Fig. 10), with near 
identical porosities, 78%, 76% and 76%, respectively. The pure silk scaffolds had a flat pore  
 
(a) 
(b) 
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Fig. 9. TEM images of MBG (a) and BG (b) powders [7]. 
morphology (Fig. 10a), whereas the MBG or BG composite scaffolds had a more open pore 
morphology (Fig. 10b and c) compared to the silk scaffolds. The pore size of the pure silk 
scaffolds ranged from several tens to one hundred micrometers; the pore size of the 
composite scaffolds is larger than that of pure silk scaffolds [33].  
The compressive strength and modulus of MBG/silk scaffolds were 420kPa and 0.70MPa, 
respectively, figures that were comparable with those of pure silk scaffolds and greater than 
those of BG/silk scaffolds (300kPa for compressive strength and 0.5MPa for modulus). It is 
speculated that the incorporation of BG particles into silk scaffolds may destroy the inner 
structure of silk and lead to the detrimental effect of the mechanical strength of silk 
scaffolds. Although MBG particles may also destroy the inner structure of silk, however, 
MBG has high surface area and pore volume, and parts of silk solution may enter into the 
nanopores of MBG during preparation, which leads to a strong bond between MBG particles 
and silk after freeze-drying. Thus, the incorporation of MBG into silk will not decrease the 
mechanical strength of silk scaffolds [33]. 
The apatite-mineralization ability and ion release of scaffolds were carried out using 
acellular simulated body fluids (SBF). The morphology of the three scaffold species, after 
soaking in SBF, is shown in Figure 11. There was no apatite particles deposit visible on the 
pore wall surfaces for pure silk and BG/silk scaffolds (Fig. 11a and b). However, a layer of 
apatite microparticles formed on the pore wall of MBG/silk scaffolds (Fig. 11c) and at 
higher magnification apatite was seen as nano-sized particles (Fig. 11d). EDS analysis 
revealed the ratio of Ca/P of the apatite to be 2.3 [33]. Apatite mineralization of silicate 
materials, such as CaSiO3 ceramics, 45S5 bioglass, etc. is thought to be an important 
phenomenon in the chemical interactions between the implant materials and the bone tissue, 
which ultimately affects the in vivo osteogenesis of the bone grafting materials [34-36]. In 
this study, MBG/silk scaffolds had an obvious apatite mineralization in SBF, whereas 
neither BG/silk nor pure silk scaffolds induced apatite mineralization. This suggests that 
MBG/silk scaffolds have an improved “in vitro bioactivity”, a term that has been used in 
previous studies [25,37,38]. 
There was a sustained release of Si ions from both the MBG/silk and BG/silk scaffolds, even 
across an extended period of soaking and the MBG/silk scaffolds had a faster rate of Si ion 
release than BG/silk scaffolds. The pH value of SBF with MBG/silk scaffolds stayed within 
a range of 7.25–7.5 throughout the 6 weeks of soaking. The pH values of the pure silk and  
 
100nm 100nm 
(a) (b) 
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Fig. 10. Surface morphology of porous silk (a), MBG/silk (b) and BG/silk (c) scaffolds. 
BG/silk scaffolds resulted in a slight decreased in SBF, varying from 7.1 to 7.4 [33]. 
Therefore, it is very obvious that the incorporation of MBG powders into silk scaffolds 
significantly improved their physio-chmestry. Further study for the effect of in vivo 
osteogenesis has been further investigated in the following section. 
50µm 
50µm 
50µm 
(a) 
(b) 
(c) 
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Fig. 11. SEM and EDS analysis silk (a), BG/silk (b) and MBG/silk (c and d) scaffolds after 
soaking in simulated body fluids for 7 days [33]. 
2.2.2 The in vivo osteogenesis of MBG-incorporated silk scaffolds 
To further investigate the in vivo osteogenesis of MBG-incorporated silk scaffolds, the 
scaffolds were implanted into calvarial defects in adult severe combined immunodeficient 
(SCID) mice and the degree of in vivo osteogenesis was evaluated by micro-computed 
tomography (μCT), hematoxylin and eosin (H&E) and immunohistochemistry (type I 
collagen) analyses. 
Both MBG/silk and BG/silk scaffolds clearly showed better bone repair ability than pure 
silk scaffolds. The defects implanted with MBG/silk scaffolds had been completely filled 
with new bone mineral tissues (Fig. 12a). The BG/silk scaffolds also induced new bone 
formation in the defects (Fig. 12b). However, the skull defects implanted with pure silk 
scaffolds revealed little mineralized tissues around the border and no new bone formation at 
all in the middle of the defects (Fig. 12c). Quantitative analysis from μCT data showed that 
the mineralized tissue volume for MBG composite was a little higher than that of BG 
composite. The volume of mineralized tissue for silk, MBG/silk and BG/silk scaffolds was 
2.5, 7.0 and 6.1 mm3, respectively (Fig. 12d) [33]. 
New bone filled most of the MBG/silk scaffolds from the edge to the center and formed a 
continuous plate of bone area (Fig. 13a and b). Most of MBG/silk scaffolds had been 
degraded (Fig. 13a). In the BG/silk scaffolds the majority of the new bone was located in the 
periphery, with some bone islands forming centrally. There was only limited degradation of 
the BG/silk scaffolds (Fig. 13c and d). In the skull defects implanted with pure silk scaffolds 
there was no evidence of bone formation. 
(d) (b) 
(c) (a) 
5 µm 5 µm 
5 µm 1 µm
www.intechopen.com
 Biomaterials Science and Engineering 
 
280 
 
 
 
 
 
 
Fig. 12. Micro-CT analysis for the in vivo bone formation of MBG/silk (a), BG/silk (b), silk 
(c) scaffolds, and new bone volume (d) after implanted in calvarial defects of SCID mice for 
8 weeks [33]. 
Immunohistochemical analysis revealed type I collagen (COL1) expression in the de novo 
bone in both MBG/silk and BG/silk scaffolds (Fig. 14); there was certainly slightly strong 
COL1 expression in the bone matrix of the MBG/silk scaffolds (Fig. 14a and b) and this 
expression was discernibly stronger compared to that in the BG/silk scaffolds (Fig. 14c and 
d) [33]. 
(a) (b) 
(d) 
(c) 
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Fig. 13. The in vivo bone formation was evaluated by hematoxylin and eosin (H & E) 
staining. (a) and (b): MBG/silk;  (c) and (d): BG/silk. (b) and (d) are higher magnification 
images. Arrows point to new formed bone [33].  
There are three reasons that best explains why MBG/silk scaffolds have improved new-
bone formation, compared to BG/silk scaffolds [33]: (1) apatite mineralization plays an 
important role in bone repair and studies suggest that apatite mineralization of 45S5 
bioglass [36], A–W bioactive glass ceramics [39] and CaSiO3 ceramics [34,40], is the direct 
factor influencing the in vivo osteogenesis potential of these materials. In the present 
study, we show that MBG/silk has a better apatite-mineralization ability than does 
BG/silk, leading us to draw the tentative conclusion that this may be one of the most 
important factors to improve new-bone formation. (2) The faster rate of dissolution and Si 
ion release of the MBG/silk scaffolds compared to BG/silk scaffolds may enhance new-
bone formation; this is supported by a study that showed that CaSiO3 ceramics has 
significantly faster rate of degradation than does β-tricalcium phosphate ceramics and 
leads to an improved in vivo osseointegration [34]. It has been reported that Si ions may be 
associated with the initiation of pre-osseous tissue mineralization, both in periosteal or in 
endochondral ossification, in the early stages of calcification [41,42]. In vitro studies have 
(a) 
500µm 
(c) 
500µm 
(b) 
200µm 
(d) 
200µm 
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confirmed that silicon released from the materials results in a significant up-regulation of 
osteoblast proliferation and gene expression [26,43,44]. The faster rate of degradation may 
in fact provide the space and environment for matrix deposition and tissue growth [45], 
and, at the same time, the quicker release Si ions from MBG/silk scaffolds may stimulate 
the viability of osteoblast around the defects, to the benefit of in vivo osteogenesis. (3) One 
cannot overlook the beneficial role that the stable pH environment of MBG/silk scaffolds 
has on in vivo osteogenesis [46,47].  
 
 
 
 
 
 
 
Fig. 14. Immunohistochemical analysis by Collagen I staining on the new bone tissues. (a) 
and (b): MBG/silk; (c) and (d): BG/silk. (b) and (d) are higher magnification images [33].  
3. Conclusion 
In summary, we have successfully developed scaffolds containing MBG and silk 
components for the purpose of bone tissue engineering. Two approaches in scaffold 
fabrication have been investigated, namely silk surface-coating for MBG scaffolds and MBG 
integrated silk scaffold. 
(a) 
500µm 
(b) 
200µm 
(d) 
200µm 
(c) 
500µm 
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Porous silk-modified MBG scaffolds with high porosity and large-pore size have been 
prepared by coating silk on the pore walls surfaces of MBG scaffolds. Silk modification 
improves the continuity of pore network and mechanical strength of MBG scaffolds, 
resulting enhanced BMSC proliferation, differentiation and in vivo bone formation. 
We have prepared MBG powders-incorporated silk scaffolds and found that MBG can 
significantly improve the in vitro bioactivity and in vivo osteogenesis of silk scaffolds. 
MBG/silk scaffolds have the improved physio-chemistry and new-bone formation ability 
compared to BG/silk scaffolds. 
Our study indicates that MBG/silk composite scaffolds, in the forms of silk-modified MBG 
scaffolds and MBG powder-integrated silk scaffolds, are very promising potential 
biomaterials for bone repair and regeneration.  
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